Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

777814

	registered interest
	date	25/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescription Drugs: Prices
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which prescription drugs had the highest increase in price to the NHS in the last 10 years for which data is available.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Chris Ruane
	uin	109619
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The table below shows the top five individual medicines <del class="ministerial">and chemicals</del> that have shown the highest increase in <ins class="ministerial">cost</ins> <del class="ministerial">price </del> over the last 10 years for Net Ingredient Cost (NIC) per prescription item <del class="ministerial">and NIC per quantity</del>. Prescription medicines<del class="ministerial">/chemicals</del> have only been included where there was prescribing in both 2006 and 2016.</p><p><ins class="ministerial">For any medicine listed, it does not necessarily mean that the price has increased. For example, the cost per prescription item will be higher if the quantity being prescribed per prescription item has increased.</ins></p><p>This is based on Prescription Cost Analysis (PCA) data. PCA data is based on analysis of all prescriptions dispensed in the community i.e. by community pharmacists and appliance contractors, dispensing doctors, and prescriptions submitted by prescribing doctors for items personally administered in England. PCA data do not cover drugs dispensed in hospitals, including mental health trusts, or private prescriptions.</p><p> </p><p>Costs vary over time due to numerous factors including medicines going off patent and becoming available generically, unlicensed medicines becoming licensed medicines, shortages, the level of competition for generic medicines, as well as centrally agreed pricing schemes such as the Pharmaceutical Price Regulation Scheme.</p><p> </p><p>The Department is working closely with the Competition and Markets Authority on a number of investigations into unwarranted price rises of unbranded generic medicines. Where companies have breached competition law, we will seek damages and invest that money back into the National Health Service.</p><p> </p><table><tbody><tr><td colspan="4"><p>The top five medicines with the highest increase in Net Ingredient<sup>1</sup> Cost per prescription item<sup>2</sup></p></td></tr><tr><td><p>Drug Name</p></td><td><p>2006</p></td><td><p>2016</p></td><td><p>Increase</p></td></tr><tr><td><p>Orfadin_Cap 10mg</p></td><td><p>£5,436.74</p></td><td><p>£20,030.86</p></td><td><p>£14,594.12</p></td></tr><tr><td><p>Cerezyme_I/V Inf 400u Vl (Dry)</p></td><td><p>£18,143.17</p></td><td><p>£30,397.85</p></td><td><p>£12,254.68</p></td></tr><tr><td><p>Chenodeoxycholic Acid_Cap 250mg</p></td><td><p>£88.57</p></td><td><p>£9,580.10</p></td><td><p>£9,491.54</p></td></tr><tr><td><p>Trientine Dihydroch_Cap 300mg (Old)</p></td><td><p>£218.58</p></td><td><p>£5,488.22</p></td><td><p>£5,269.64</p></td></tr><tr><td><p>Sod Benz_Liq Spec 400mg/5ml</p></td><td><p>£361.95</p></td><td><p>£4,352.92</p></td><td><p>£3,990.96</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis</p><p> </p><p>Notes:</p><p> </p><p><sup>1</sup>NIC is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charges income, so the amount the NHS spent will be slightly different.</p><p> </p><p><sup>2</sup>Prescriptions are written on a prescription form known as an FP10. Each single item written on the form is counted as a prescription item.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 14:32:18 question first ministerially corrected 12/12/2017 13:55:12 answering member 4067 label Biography information for Steve Brine previous answer version 20077 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	534 label Biography information for Chris Ruane

778216

	registered interest
	date	26/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Tobacco: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent assessment he has made of the effect of the introduction of plain cigarette packaging on smoking rates.
	tabling member constituency	Brentwood and Ongar
	tabling member printed	Alex Burghart
	uin	110024
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The Standardised Packaging of Tobacco Products Regulations 2015 came into force on 20 May 2016. The Government consulted on the introduction of standardised packaging and published an impact assessment, which included benefits to public health. The Government will review these regulations by <ins class="ministerial">2021</ins> <del class="ministerial">2020</del>.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 11:41:50 question first ministerially corrected 21/03/2018 13:09:21 answering member 4067 label Biography information for Steve Brine previous answer version 19960 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	4613 label Biography information for Alex Burghart

777660

	registered interest
	date	25/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Kidney Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to improve the prognosis for (a) adults and (b) children diagnosed with kidney disease.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	109519
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>NHS England commissions specialist renal services for adults, children and young people and has recently published renal service specifications (that cover dialysis, acute kidney injury, renal assessment and transplantation) that should lead to uniform high levels of kidney care across England. Further information can be found via the following link:</p><p><a href="http://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-a/a06/" target="_blank">www.england.nhs.uk/commissioning/spec-services/npc-crg/group-a/a06/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 11:38:17 answering member 4067 label Biography information for Steve Brine
	tabling member	411 label Biography information for Mr Barry Sheerman

777831

	registered interest
	date	25/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Carbon Monoxide: Poisoning
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate his Department has made of the cost to the NHS of treating carbon monoxide poisoning in the last 12 months.
	tabling member constituency	Walsall North
	tabling member printed	Eddie Hughes
	uin	109718
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The Department has not made an estimate of the cost to the National Health Service of treating carbon monoxide poisoning in the last 12 months. The 2016-17 annual report of the Cross-Government Group on Gas Safety and Carbon Monoxide is being prepared and will be published on the Health and Safety Executive website:</p><p><a href="http://www.hse.gov.uk/gas/domestic/cross-government-group.htm" target="_blank">http://www.hse.gov.uk/gas/domestic/cross-government-group.htm</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 11:40:34 answering member 4067 label Biography information for Steve Brine
	tabling member	4635 label Biography information for Eddie Hughes

778210

	registered interest
	date	26/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Alcoholic Drinks: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to promote the consumption of lower strength alcohol.
	tabling member constituency	Ribble Valley
	tabling member printed	Mr Nigel Evans
	uin	109960
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The 2016 UK Chief Medical Officers low risk drinking guidelines provide the public with the most up to date scientific information to help people make informed decisions about their own drinking. Guidance on low risk drinking is also contained in the Public Health England ‘One You’ campaign. The alcohol industry made a pledge in 2012 to reduce alcoholic strength of its products, which has seen 1.3 billion units of alcohol removed from people’s drinks.</p><p>The Department held workshops last autumn with industry and public health experts, with the aim of encouraging the public to move towards lower strength alcoholic drinks from the industry standard, and commissioned research on the impact of developing and introducing new descriptors for alcoholic products above 1.2% alcohol by volume (ABV).</p><p>There have been no recent discussions between the Secretary of State for Health and Chancellor of the Exchequer on promoting low-strength alcohol beverages.</p><p>The duty rates on beer, cider, wine and spirits increased by Retail Price Index inflation, in line with the previous forecasts, including financial incentives to produce lower levels of alcohol. Rates were published on 13 March 2017 and are available here:</p><p><a href="https://www.gov.uk/government/publications/rates-and-allowance-excise-duty-alcohol-duty/alcohol-duty-rates-from-24-march-2014" target="_blank">https://www.gov.uk/government/publications/rates-and-allowance-excise-duty-alcohol-duty/alcohol-duty-rates-from-24-march-2014</a></p><p>Earlier this year the Government also launched a consultation on options to ensure duty rates for cider and wine better correspond to alcoholic strength, and to encourage the production and consumption of lower strength drinks. One option looked at the impacts of a new low-strength wine band between 5.5% and 8.5% ABV. The Government is currently considering all consultation responses and will announce its next steps in due course.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 109961 109962 question first answered 03/11/2017 11:49:42 answering member 4067 label Biography information for Steve Brine
	tabling member	474 label Biography information for Mr Nigel Evans

778211

	registered interest
	date	26/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Alcoholic Drinks: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what discussions he has had with the alcohol industry on introducing lower strength alcohol across the UK.
	tabling member constituency	Ribble Valley
	tabling member printed	Mr Nigel Evans
	uin	109961
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The 2016 UK Chief Medical Officers low risk drinking guidelines provide the public with the most up to date scientific information to help people make informed decisions about their own drinking. Guidance on low risk drinking is also contained in the Public Health England ‘One You’ campaign. The alcohol industry made a pledge in 2012 to reduce alcoholic strength of its products, which has seen 1.3 billion units of alcohol removed from people’s drinks.</p><p>The Department held workshops last autumn with industry and public health experts, with the aim of encouraging the public to move towards lower strength alcoholic drinks from the industry standard, and commissioned research on the impact of developing and introducing new descriptors for alcoholic products above 1.2% alcohol by volume (ABV).</p><p>There have been no recent discussions between the Secretary of State for Health and Chancellor of the Exchequer on promoting low-strength alcohol beverages.</p><p>The duty rates on beer, cider, wine and spirits increased by Retail Price Index inflation, in line with the previous forecasts, including financial incentives to produce lower levels of alcohol. Rates were published on 13 March 2017 and are available here:</p><p><a href="https://www.gov.uk/government/publications/rates-and-allowance-excise-duty-alcohol-duty/alcohol-duty-rates-from-24-march-2014" target="_blank">https://www.gov.uk/government/publications/rates-and-allowance-excise-duty-alcohol-duty/alcohol-duty-rates-from-24-march-2014</a></p><p>Earlier this year the Government also launched a consultation on options to ensure duty rates for cider and wine better correspond to alcoholic strength, and to encourage the production and consumption of lower strength drinks. One option looked at the impacts of a new low-strength wine band between 5.5% and 8.5% ABV. The Government is currently considering all consultation responses and will announce its next steps in due course.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 109960 109962 question first answered 03/11/2017 11:49:42 answering member 4067 label Biography information for Steve Brine
	tabling member	474 label Biography information for Mr Nigel Evans

778212

	registered interest
	date	26/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Alcoholic Drinks: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what discussions he has had with the Chancellor of the Exchequer on promoting low-strength alcoholic beverages.
	tabling member constituency	Ribble Valley
	tabling member printed	Mr Nigel Evans
	uin	109962
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The 2016 UK Chief Medical Officers low risk drinking guidelines provide the public with the most up to date scientific information to help people make informed decisions about their own drinking. Guidance on low risk drinking is also contained in the Public Health England ‘One You’ campaign. The alcohol industry made a pledge in 2012 to reduce alcoholic strength of its products, which has seen 1.3 billion units of alcohol removed from people’s drinks.</p><p>The Department held workshops last autumn with industry and public health experts, with the aim of encouraging the public to move towards lower strength alcoholic drinks from the industry standard, and commissioned research on the impact of developing and introducing new descriptors for alcoholic products above 1.2% alcohol by volume (ABV).</p><p>There have been no recent discussions between the Secretary of State for Health and Chancellor of the Exchequer on promoting low-strength alcohol beverages.</p><p>The duty rates on beer, cider, wine and spirits increased by Retail Price Index inflation, in line with the previous forecasts, including financial incentives to produce lower levels of alcohol. Rates were published on 13 March 2017 and are available here:</p><p><a href="https://www.gov.uk/government/publications/rates-and-allowance-excise-duty-alcohol-duty/alcohol-duty-rates-from-24-march-2014" target="_blank">https://www.gov.uk/government/publications/rates-and-allowance-excise-duty-alcohol-duty/alcohol-duty-rates-from-24-march-2014</a></p><p>Earlier this year the Government also launched a consultation on options to ensure duty rates for cider and wine better correspond to alcoholic strength, and to encourage the production and consumption of lower strength drinks. One option looked at the impacts of a new low-strength wine band between 5.5% and 8.5% ABV. The Government is currently considering all consultation responses and will announce its next steps in due course.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 109960 109961 question first answered 03/11/2017 11:49:43 answering member 4067 label Biography information for Steve Brine
	tabling member	474 label Biography information for Mr Nigel Evans

778215

	registered interest
	date	26/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Fatigue Syndrome: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will respond to Early Day Motion 271, entitled NICE guidelines on ME.
	tabling member constituency	Glasgow North
	tabling member printed	Patrick Grady
	uin	109997
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) guidance set outs best practice for clinicians on the diagnosis, treatment care and support of people with myalgic encephalomyelitis and supports commissioners to to plan services for local populations. The full guidance can be found at the following link:</p><p><a href="http://www.nice.org.uk/guidance/cg53" target="_blank">www.nice.org.uk/guidance/cg53</a></p><p>On 20 September 2017, NICE announced its decision to undertake a full update of the guidance. More information on this decision can be found at the following link:</p><p><a href="http://www.nice.org.uk/guidance/cg53/resources/surveillance-report-2017-chronic-fatigue-syndromemyalgic-encephalomyelitis-or-encephalopathy-diagnosis-and-management-2007-nice-guideline-cg53-pdf-5964455783941" target="_blank">www.nice.org.uk/guidance/cg53/resources/surveillance-report-2017-chronic-fatigue-syndromemyalgic-encephalomyelitis-or-encephalopathy-diagnosis-and-management-2007-nice-guideline-cg53-pdf-5964455783941</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 11:43:51 answering member 4067 label Biography information for Steve Brine
	tabling member	4432 label Biography information for Patrick Grady

778221

	registered interest
	date	26/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the effect of flash glucose monitoring on the management of diabetes.
	tabling member constituency	Tynemouth
	tabling member printed	Mr Alan Campbell
	uin	109900
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>Freestyle Libre, a flash glucose monitoring system has been approved for reimbursement on National Health Service prescription from 1 November 2017 through listing in Part IX of the NHS England and Wales Drug Tariff.</p><p> </p><p>The NHS Business Services Authority carries out the assessment of Part IX applications made by manufacturers on behalf, of the Secretary of State for Health, for prescribing at NHS expense by an appropriate practitioner.</p><p> </p><p>The listing of a medical device in the Drug Tariff should not be interpreted as a recommendation to prescribe a particular product. Patients will need to discuss the ongoing management of their condition with their healthcare professional and consider whether flash glucose monitoring is suitable for them.</p><p> </p><p>Any device made available for prescribing to patients through listing in Part IX is required to meet set criteria, namely that the product is safe and of good quality, it is appropriate for general practice and, if relevant, non-medical prescribing, and it is cost effective.</p><p> </p><p>Within its financial constraints, the NHS is committed to providing access to new drugs and medical technologies. Ultimately it is for clinical commissioning groups (CCGs), who are primarily responsible for commissioning diabetes services, to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 109901 question first answered 03/11/2017 11:47:02 answering member 4067 label Biography information for Steve Brine
	tabling member	529 label Biography information for Sir Alan Campbell

778222

	registered interest
	date	26/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department takes to ensure that people with diabetes have access to new and emerging technologies as they come to market.
	tabling member constituency	Tynemouth
	tabling member printed	Mr Alan Campbell
	uin	109901
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>Freestyle Libre, a flash glucose monitoring system has been approved for reimbursement on National Health Service prescription from 1 November 2017 through listing in Part IX of the NHS England and Wales Drug Tariff.</p><p> </p><p>The NHS Business Services Authority carries out the assessment of Part IX applications made by manufacturers on behalf, of the Secretary of State for Health, for prescribing at NHS expense by an appropriate practitioner.</p><p> </p><p>The listing of a medical device in the Drug Tariff should not be interpreted as a recommendation to prescribe a particular product. Patients will need to discuss the ongoing management of their condition with their healthcare professional and consider whether flash glucose monitoring is suitable for them.</p><p> </p><p>Any device made available for prescribing to patients through listing in Part IX is required to meet set criteria, namely that the product is safe and of good quality, it is appropriate for general practice and, if relevant, non-medical prescribing, and it is cost effective.</p><p> </p><p>Within its financial constraints, the NHS is committed to providing access to new drugs and medical technologies. Ultimately it is for clinical commissioning groups (CCGs), who are primarily responsible for commissioning diabetes services, to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 109900 question first answered 03/11/2017 11:47:02 answering member 4067 label Biography information for Steve Brine
	tabling member	529 label Biography information for Sir Alan Campbell